AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Path 30 Tablet

Prescription Icon
Prescription Required

Marketer

Lupin Ltd

Salt Composition

Pioglitazone (30mg)

Overview Path 30 Tablet

Adults with type 2 diabetes mellitus may use Path 30 Tablets to manage their blood glucose levels. This medication helps prevent serious diabetic complications such as vision impairment and kidney disease. Path 30 Tablets can be prescribed as a standalone treatment or in conjunction with other medications, with or without food. Consistent daily dosing at the same time maximizes effectiveness. Your physician will determine the appropriate dosage, which may be adjusted over time based on its efficacy. Continuous use, even during periods of well-being or controlled blood sugar, is crucial. Discontinuing treatment without consulting your doctor can elevate blood sugar, increasing the risk of kidney damage, blindness, neuropathy, and limb loss. Remember, it's a component of a broader treatment strategy involving a healthy diet, exercise, and weight management as recommended by your doctor. Lifestyle choices significantly influence diabetes management. Common side effects include headache, sinusitis, myalgia, and pharyngitis. Report persistent or bothersome side effects to your doctor. This medication is contraindicated for individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior to initiating treatment, inform your doctor of any history of heart disease, thyroid disorders, or hormonal imbalances, as it may be unsuitable. Pregnant or breastfeeding individuals should seek medical advice before use. Regular blood glucose monitoring is essential, and your doctor might also order blood tests to assess blood cell counts and liver function.

Uses of Path 30 Tablet

Managing type 2 diabetes

Major Benefits of Path 30 Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; do not crush, chew, or divide it. Path 30 Tablet can be administered with or without food, though consistent timing is recommended.

Common Side effects of Path 30 Tablet:

  • Headache
  • Sore throat
  • Sinus inflammation
  • Muscle pain

How to use Path 30 Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablets whole; avoid chewing, crushing, or breaking them. Path 30 Tablets can be administered with or without food, though consistent timing is recommended.

How Path 30 Tablet works:

Glycemic control is achieved with Path 30 Tablets, an antidiabetic agent that enhances the body's responsiveness to insulin, thereby regulating blood glucose.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol concurrently with Path 30 Tablet is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Path 30 Tablet during pregnancy might pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible dangers before recommending its use. Seek medical advice.

Breast feedingBreast feedingCAUTION

Exercise caution when using Path 30 Tablet while breastfeeding. Discontinue breastfeeding until the mother's treatment concludes and the medication is fully cleared from her system. Closely observe the infant's blood glucose levels throughout the mother's treatment with Path 30 Tablet.

DrivingDrivingSAFE

Driving ability is typically unaffected by Path 30 Tablet.

KidneyKidneySAFE IF PRESCRIBED

Path 30 Tablet presents no contraindication for use in patients with renal impairment; dosage modification is unnecessary.

LiverLiverCAUTION

Individuals with hepatic impairment should exercise caution when using Path 30 Tablet, potentially requiring dosage modification. Physician consultation is advised. Path 30 Tablet is contraindicated in patients exhibiting severe liver dysfunction.

What if you forget to take Path 30 Tablet :

Omit any missed Path 30 Tablet dose and resume your regular medication schedule. Avoid taking a double dose.

Facts to Know About Path 30 Tablet

LabelValue
Chemical Type TZD Derivative
Developing Habits No.
Treatment Category Diabetes Management
Actions PPAR gamma agonist (thiazolidinedione)

FAQs on Path 30 Tablet

Path 30 Tablet is often associated with weight gain, potentially linked to dosage. This weight gain may result from fat accumulation, or, in patients with heart failure, from fluid retention. Consequently, weight monitoring is crucial for heart failure patients taking this medication.
Path 30 Tablet may cause fluid retention, potentially worsening or accelerating heart failure. Treatment for patients with a heart failure risk factor (e.g., prior heart attack, coronary artery disease, advanced age) typically begins with the lowest dose, gradually increasing as needed. Concomitant use of Path 30 Tablet and insulin increases the risk of heart failure.
Path 30 Tablet can augment metformin therapy in adults with type 2 diabetes who haven't achieved adequate blood sugar control with metformin alone, particularly those who are overweight.
Take Path 30 Tablet once daily, at the same time each day if possible, with or without food, as directed by your doctor.
Follow your doctor's instructions regarding Path 30 Tablet. Diabetes treatment often requires lifelong medication, but if you need to discontinue use, consult your doctor for alternative options. Stopping abruptly without medical advice may dangerously increase your blood sugar.
Path 30 Tablet can raise liver enzyme levels; discontinue use if this occurs. Regular liver enzyme monitoring is necessary during treatment. This medication is contraindicated in patients with liver disease.
Path 30 Tablet, a thiazolidinedione, manages blood sugar by enhancing your body's insulin utilization. This works by increasing your cells' sensitivity to insulin.
Path 30 Tablet may rarely increase bladder cancer risk. Seek immediate medical attention if you experience hematuria, dysuria, or urinary urgency while taking this medication. Patients with a history of bladder cancer should not use Path 30 Tablet.
Path 30 Tablet
109
MRP 133
17% off